Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...

Johnson & Johnson sealed its biggest deal in six years by acquiring cardiovascular med tech company Abiomed for $16.6 billion, the company announced Tuesday. Abiomed, which develops heart pumps, will ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...

Forbes Technology Council Is an Invitation-Only Community for World-Class CIOs, CTOs, and Technology Executives. Cardio Diagnostics is a biotechnology company that makes cardiovascular disease ...

ASX-listed health tech firm CardieX announced it acquired Silicon Valley-based Blumio, a developer of cardiovascular sensor algorithms and data analytics tools. CardieX focuses on hypertension, ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

Levron Medical Ltd. recently exited stealth mode to advance its cardio-respiratory physiology assist technology, designed to treat heart failure by synchronizing the heart and lungs. The approach ...

CHICAGO--(BUSINESS WIRE)--Meesha Dogan, PhD, the CEO of Cardio Diagnostics (Nasdaq: CDIO), a precision cardiovascular disease company, has been accepted into Forbes Technology Council, an ...